0001144204-15-054653.txt : 20150911 0001144204-15-054653.hdr.sgml : 20150911 20150911162652 ACCESSION NUMBER: 0001144204-15-054653 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150911 DATE AS OF CHANGE: 20150911 EFFECTIVENESS DATE: 20150911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Protea Biosciences Group, Inc. CENTRAL INDEX KEY: 0001335103 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-247477 FILM NUMBER: 151103608 BUSINESS ADDRESS: STREET 1: 955 HARTMAN RUN ROAD CITY: MORGANTOWN STATE: WV ZIP: 26505 BUSINESS PHONE: 304 292-2226 MAIL ADDRESS: STREET 1: 955 HARTMAN RUN ROAD CITY: MORGANTOWN STATE: WV ZIP: 26505 FORMER COMPANY: FORMER CONFORMED NAME: Protea Biosciences Inc. DATE OF NAME CHANGE: 20110908 FORMER COMPANY: FORMER CONFORMED NAME: SRKP 5 INC DATE OF NAME CHANGE: 20050803 D 1 primary_doc.xml X0707 D LIVE 0001335103 Protea Biosciences Group, Inc. 1311 PINEVIEW DRIVE, SUITE 501 MORGANTOWN WV WEST VIRGINIA 26505 304 292-2226 DELAWARE SRKP 5, Inc. Protea Biosciences Inc. SRKP 5 INC Corporation true Stephen A. Turner c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Executive Officer Director President, CEO, Chairman of the Board of Directors Stanley Hostler c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 1311 Pineview Drive, Suite 501 WV WEST VIRGINIA 26505 Executive Officer Director Secretary Leonard Harris c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Ed Roberson c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Scott Segal c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Josiah T. Austin c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Patrick Gallagher c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Maged Shenouda c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Matthew Powell c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Executive Officer Vice President, Research & Development Gregory Kilby c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Executive Officer Vice President, Operations Biotechnology $1,000,001 - $5,000,000 06b false 2015-08-27 false true true false 100000 Laidlaw & Company (UK) Ltd. 119037 None None 546 FIFTH AVENUE 5TH FLOOR NEW YORK NY NEW YORK 10036 CA CALIFORNIA KS KANSAS KY KENTUCKY NJ NEW JERSEY NY NEW YORK WA WASHINGTON false 4000000 452500 3547500 false 8 52500 0 Included in the sales commission is a 2% non-accountable expense allowance. Laidlaw also received warrants to purchase 43,000 shares of common stock of the Issuer for sales to persons that were not pre-existing investors of Protea. 0 false Protea Biosciences Group, Inc. /s/ Stephen A. Turner Stephen A. Turner President, CEO, Chairman of the Board 2015-09-11